New conflicting results obtained in the subgroup analysis of RAD51 135G>C polymorphism and breast cancer risk

[1]  Weibo Liang,et al.  RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies , 2011, Breast Cancer Research and Treatment.

[2]  Zhanwei Wang,et al.  RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects , 2010, Breast Cancer Research and Treatment.

[3]  J. Błasiak,et al.  Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. , 2008, Mutation research.

[4]  F. Couch,et al.  RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. , 2007, American journal of human genetics.

[5]  R. Scott,et al.  The RAD51 135 G>C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA1 Mutation Carriers , 2007, Cancer Epidemiology Biomarkers & Prevention.

[6]  A. Kulig,et al.  Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer. , 2006, Experimental oncology.

[7]  R. Eeles,et al.  A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers , 2004, British Journal of Cancer.

[8]  B. Modan,et al.  A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  Jia Hu,et al.  RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis , 2010, Breast Cancer Research and Treatment.

[10]  V. Tarasov,et al.  Genetically determined subdivision of human populations with respect to the risk of breast cancer in women , 2006, Doklady Biological Sciences.